Close Menu

NEW YORK – Promega said on Tuesday that it has received CE marking for its OncoMate MSI Dx Analysis System, allowing it to make the test available as an in vitro diagnostic medical device in Europe.

OncoMate MSI is a PCR-based assay that measures microsatellite instability status in tissue samples from solid tumors. According to Promega, the kit offers high analytical sensitivity and specificity with a short turnaround time.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The founder of MeTooSTEM, BethAnn McLaughlin, created a Twitter account purported to be that of an LGBTQ Native American professor at Arizona State University, the New York Times writes.

Novavax reports its candidate SARS-CoV-2 vaccine leads to immune responses, according to the Sydney Morning Herald.

Gene length is associated with lifespan in a comparative genomics study appearing in the Proceedings of the National Academy of Sciences that draws on the whale shark genome.

In Nucleic Acids Research this week: effort to annotate the rat transcriptome, web-based resource to characterize marine microbes, and more.